Service provider

ConnectWise Honored on CRN AI 100 List for Offering Innovating AI Solutions

Retrieved on: 
Monday, April 8, 2024
Microsoft, Automation, Business administration, CRN (magazine), GM, Growth, EVP, TEAMS, Intelligence, RPA, Satellite navigation, Software, AI, Editing, Life, Service provider, CRN, Investment, Microsoft Teams, Robotic process automation, The Channel Company, Sales

CRN is launching the AI 100 list at a critical time in the IT market as solution providers are now making critical investments in their AI portfolios that will drive unprecedented opportunities growth in 2024 and beyond.

Key Points: 
  • CRN is launching the AI 100 list at a critical time in the IT market as solution providers are now making critical investments in their AI portfolios that will drive unprecedented opportunities growth in 2024 and beyond.
  • Selected by a panel of CRN editors, vendors on the AI 100 list are recognized for the strength of their AI portfolios, commitment to innovation, and ability to support IT channel partners as they bring AI solutions to life.
  • "ConnectWise is committed to empowering TSPs with cutting-edge AI and hyperautomation solutions through ConnectWise SideKick and RPA," said Jake Varghese, EVP and GM, Business Management at ConnectWise.
  • We look forward to seeing how they contribute to AI excellence in the channel going forward.”
    The 2024 CRN AI 100 list will be featured in the April issue of CRN Magazine and online at www.CRN.com/AI100 beginning April 8, 2024.

Zymeworks Presents New Data from Multiple Preclinical Development Programs at 2024 American Association for Cancer Research Annual Meeting

Retrieved on: 
Monday, April 8, 2024
Well, Small-cell carcinoma, Therapeutic index, Glomus tumor, Endometrial cancer, Survival, Environment, Service provider, Trichloroethylene, Patient, Primate, Triple-negative breast cancer, Lead, Zymeworks, 3D, Standard of care, Cancer, TAA, Spacecraft, Lung cancer, IND, CD3, DLL3, AACR, Workflow, Antibody, TCE, CD28, Therapy, Stomach, ADC, Vaccine

The compelling preclinical activity profile supports ZW191 development across multiple tumor types, including FRα-high/mid/low ovarian cancers and other FRα-expressing indications, including non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer.

Key Points: 
  • The compelling preclinical activity profile supports ZW191 development across multiple tumor types, including FRα-high/mid/low ovarian cancers and other FRα-expressing indications, including non-small cell lung cancer, endometrial cancer, and triple-negative breast cancer.
  • An investigational new drug (IND) submission or foreign equivalent is planned for 2024.
  • Small cell lung cancer (SCLC) is an aggressive neuroendocrine cancer with a poor prognosis and high unmet medical need2.
  • Displays no cross-linking of T cells and exhibits obligate cis T cell binding of CD28, requiring co-engagement of CD3.

Nonprofit Money Management International (MMI) Reveals Insights on the Hispanic Financial Experience

Retrieved on: 
Wednesday, March 27, 2024
Foreign policy, Hispanic, MBE, Minority business enterprise, Education, Research, MMI, Money Management International, Senior counsel, Service provider, Perception, JPMorgan Chase

The study sheds light on the unique financial experiences and challenges faced by Hispanic consumers.

Key Points: 
  • The study sheds light on the unique financial experiences and challenges faced by Hispanic consumers.
  • Debt Perception and Management: Hispanics expressed negative feelings towards debt, with a strong desire for education and support to effectively manage their financial obligations.
  • "We have been committed to serving the Hispanic community for decades, and we are excited about the potential this research unlocks.
  • By understanding the nuances of Hispanic financial experience, we can evolve our outreach and programs to continue to meet their unique needs," said Michelle Jones , Chief External Affairs Officer at MMI.

Virtual Internet Announces Virtual 5G Service Provider Control

Retrieved on: 
Monday, April 8, 2024
Cloud, Telephone, Speedtest.net, Primary, EV, Worldwide, End user, Mobile phone, Memory, Risk, Accounting, SAN, Frequency, Location, Internet, Data, Tablet, Health care, Radio access network, GPS, Communication, Life, IP address, Reliability, City, Service, Data-rate units, End, Investment, Service provider, RAN, Central processing unit, Secondary, Android

Virtual 5G --The Global 5G Cloud

Key Points: 
  • SINGAPORE and SAN JOSE, Calif., April 8, 2024 /PRNewswire/ -- Virtual Internet has announced Virtual 5G Service Provider Control, enabling V5G Users with the insight to manage the Service Provider and Device selections.
  • Virtual 5G uniquely delivers Global 5G service over any service provider network, even when the underlying Service Provider connection is not 5G, to End User devices that are also not 5G.
  • Virtual 5G Service Provider Control enables gathering Android hardware data and valuable insights into your device's operations, enabling Virtual 5G users to make selections that troubleshoot service provider issues and optimize performance.
  • Virtual 5G and Virtual 5G Service Provider Control can be the difference in successfully reaching charging resources in time.

IBM and The Government of Spain Collaborate to Advance National AI Strategy and Build the World's Leading Spanish Language AI Models

Retrieved on: 
Friday, April 5, 2024
Research, Economy, Government, Catalan, Civil service, Growth, SME, Intelligence, Executive, Knowledge, Luigi, Service provider, Software, IBM, Senior, LLM, Digital transformation, Memorandum of understanding, Palace of Moncloa, Ecosystem, IBM Research, Safety, Public sector, Ministry, Memorandum, Artificial intelligence, Medical device

MADRID, April 5, 2024 /PRNewswire/ -- The President of the Government, Pedro Sánchez, and the Senior Vice President of IBM (NYSE: IBM) and Director of IBM Research, Darío Gil, met this afternoon at the Moncloa Complex, where they celebrated the new agreement reached between the Executive and IBM that will allow the development of foundational models for Artificial Intelligence, native in Spanish and co-official languages. During the meeting, which was also attended by the Minister for Digital Transformation and the Civil Service, José Luis Escrivá; the director of the Office of Economic Affairs of the Presidency of the Government, Manuel de la Rocha, and the president of IBM Spain, Portugal, Greece and Israel, Horacio Morell, they shared challenges and initiatives that are opening up in the field of artificial intelligence and supercomputing.  

Key Points: 
  • "IBM shares this bold vision to accelerate the Government of Spain's AI strategy and to be the national AI partner for Spain," said Darío Gil, IBM SVP and Director of IBM Research.
  • One of the priority areas under this MoU is to collaborate in a leading suite of foundation models, including both large language models (LLMs) and small language models (SLMs), proficient in the Spanish language and co-official languages.
  • Creating models that are entirely designed in Spanish will enhance AI sustainability by reducing biases and providing competitive alternatives for the Spanish industry.
  • An additional priority described under this memorandum is to collaborate on the research and development of AI technology for supercomputing applications.

IBM and The Government of Spain Collaborate to Advance National AI Strategy and Build the World's Leading Spanish Language AI Models

Retrieved on: 
Friday, April 5, 2024
Research, Economy, Government, Catalan, Civil service, Growth, SME, Intelligence, Executive, Knowledge, Luigi, Service provider, Software, IBM, Senior, LLM, Digital transformation, Memorandum of understanding, Palace of Moncloa, Ecosystem, IBM Research, Safety, Public sector, Ministry, Memorandum, Artificial intelligence, Medical device

MADRID, April 5, 2024 /PRNewswire/ -- The President of the Government, Pedro Sánchez, and the Senior Vice President of IBM (NYSE: IBM) and Director of IBM Research, Darío Gil, met this afternoon at the Moncloa Complex, where they celebrated the new agreement reached between the Executive and IBM that will allow the development of foundational models for Artificial Intelligence, native in Spanish and co-official languages. During the meeting, which was also attended by the Minister for Digital Transformation and the Civil Service, José Luis Escrivá; the director of the Office of Economic Affairs of the Presidency of the Government, Manuel de la Rocha, and the president of IBM Spain, Portugal, Greece and Israel, Horacio Morell, they shared challenges and initiatives that are opening up in the field of artificial intelligence and supercomputing.  

Key Points: 
  • "IBM shares this bold vision to accelerate the Government of Spain's AI strategy and to be the national AI partner for Spain," said Darío Gil, IBM SVP and Director of IBM Research.
  • One of the priority areas under this MoU is to collaborate in a leading suite of foundation models, including both large language models (LLMs) and small language models (SLMs), proficient in the Spanish language and co-official languages.
  • Creating models that are entirely designed in Spanish will enhance AI sustainability by reducing biases and providing competitive alternatives for the Spanish industry.
  • An additional priority described under this memorandum is to collaborate on the research and development of AI technology for supercomputing applications.

Nano Dimension Announces Record 2023 Revenue of $56.3 Million and Organic Growth of 29%

Retrieved on: 
Thursday, March 21, 2024
Research, Service provider, Attention, ROI, Senior, RET, Tower Semiconductor, Initiative, AME, Share repurchase, Sale, 3D, Acquisition, G&A, Aviation, Multi, ADS, Record, Nano, Robotics, Annual general meeting, PCB, Vice president, Workforce, Patent, 3D printing, Fraunhofer Society, Marketing, Corporate development, Human, Army, Printing, Video game

WALTHAM, Mass., March 21, 2024 (GLOBE NEWSWIRE) -- Nano Dimension Ltd. (Nasdaq: NNDM, “Nano Dimension” or the “Company”), a leading supplier of Additively Manufactured Electronics (“AME”) and multi-dimensional polymer, metal & ceramic Additive Manufacturing (“AM”), today announced financial results for the fourth quarter and full year ended December 31st, 2023.

Key Points: 
  • Nano Dimension has a breadth of technologies and products assortment, yet narrow and focused span of synergistic vertical markets.
  • It is specifically designed to enable Nano Dimension to become operating income positive in 2025, and potentially cash flow positive earlier.
  • As an example, Q4/2023’s $14.5 million in revenue was 19% higher than the same period in the year before.
  • With close to $56.3 million of revenue, Nano Dimension is the fastest growing of the cohort of publicly traded AM / 3D printing companies (approximately 10-12).

CISO GLOBAL RECOGNIZED ON CRN’S 2024 MSP 500 LIST IN THE SECURITY 100 CATEGORY

Retrieved on: 
Thursday, March 21, 2024
SMB, Algorithm, Growth, Managed services, Intelligence, AI, Service provider, CRN, Security, MSP, The Channel Company, Management

(NASDAQCM: CISO), an industry leader in proprietary software, managed cybersecurity, and compliance, announced today that CRN®, a brand of The Channel Company, has named CISO Global to its Managed Service Provider (MSP) 500 list in the Security 100 category for 2024.

Key Points: 
  • (NASDAQCM: CISO), an industry leader in proprietary software, managed cybersecurity, and compliance, announced today that CRN®, a brand of The Channel Company, has named CISO Global to its Managed Service Provider (MSP) 500 list in the Security 100 category for 2024.
  • The MSP 500 list compiled by CRN serves as a comprehensive guide to identifying and recognizing the top Managed Service Providers (MSPs) in North America.
  • In addition to delivering a comprehensive suite of end-to-end managed security services, CISO Global has developed a portfolio of proactive security software powered by AI, ML, and advanced algorithms.
  • The MSP 500 list aims to showcase and celebrate MSPs that are driving growth and innovation in the industry.

Arctic Therapeutics and Nacuity Pharmaceuticals Announce European Medicines Agency Approval to Initiate First Clinical Trial of AT-001 (NPI-001) for the Treatment of HCCAA

Retrieved on: 
Tuesday, March 12, 2024
Retinitis pigmentosa, Disease, Partnership, Tablet, SVP, Stroke, Deficit spending, EMA, Cystinosis, GMP, European Medicines Agency, Clinical trial, Intraparenchymal hemorrhage, NACA, Safety, CSO, Cataract, Usher syndrome, Dementia, Oxidative stress, Amyloid, Service provider, Pharmaceutical industry

Current treatment options are severely limited, focusing primarily on symptom management rather than addressing the underlying cause of the disease.

Key Points: 
  • Current treatment options are severely limited, focusing primarily on symptom management rather than addressing the underlying cause of the disease.
  • “EMA's approval paves the way for a comprehensive investigation into the safety and efficacy of a novel therapeutic approach designed to halt or reverse the progression of HCCAA.
  • Nacuity is also currently evaluating NPI-001 in Phase 1/2 clinical trials in Australia for retinitis pigmentosa associated with Usher syndrome and cystinosis.
  • “Our proprietary NPI-001 has potential to address the myriad diseases and conditions where oxidative stress plays a role.

China Genetic Testing Market Report 2024-2032 Featuring BGI, Berry Genomics, Daan Gene, WuXi NextCODE, Annoroad Gene Technology, and WuXi PharmaTech - ResearchAndMarkets.com

Retrieved on: 
Wednesday, March 27, 2024
Technology, Medical Devices, Hospitals, Science, Genetics, Nursing, Medical Supplies, Biotechnology, Health, Health Technology, Health Insurance, Other Science, Research, Other Technology, Insurance, Stem Cells, Oncology, Pregnancy, Growth, Genetic testing, COVID-19, Conditional sentence, SWOT, History, Policy, DTC, Service provider, Genetic disorder, DSM-IV codes, Consultant, Ageing, Vaccine

The "China Genetic Testing Market Report by Test Type, Disease, Technology, Service Provider, Testing Sample 2024-2032" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "China Genetic Testing Market Report by Test Type, Disease, Technology, Service Provider, Testing Sample 2024-2032" report has been added to ResearchAndMarkets.com's offering.
  • This report provides a deep insight into the China genetic testing market covering all its essential aspects.
  • What is the breakup of the China genetic testing market based on the testing sample?
  • Who are the key players/companies in the China genetic testing market?